⌘K
Loading ticker…
As of 2026-08-24, Standard BioTools Inc. Common Stock (LAB) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.3%, relative volume 0.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LAB is in a stage 4 downtrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -19.8% / -40.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
LAB is held by 15 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $4M.
Held by 27 ETFs · $31M across latest filings · largest weight 0.41% (QQQS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.00% | $852K | — |
| VTWV | 0.02% | $255K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $209K | — |
| GNOM | 0.35% | $196K | +0.09 pp |
| MSSM | 0.02% | $163K | — |
| QQQS | 0.41% | $78K | +0.06 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $25K | — |
| WSML | 0.00% | $21K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LAB Jan avg: 17.90% median: 6.04% win: 75% σ: 36.41% n: 4 2022-04-12 → 2026-07-31 | LAB Feb avg: -15.11% median: -14.14% win: 0% σ: 13.15% n: 4 2022-04-12 → 2026-07-31 | LAB Mar avg: 2.59% median: 4.28% win: 75% σ: 16.25% n: 4 2022-04-12 → 2026-07-31 | LAB Apr avg: -9.77% median: -8.49% win: 40% σ: 13.70% n: 5 2022-04-12 → 2026-07-31 | LAB May avg: 4.88% median: 0.00% win: 60% σ: 26.53% n: 5 2022-04-12 → 2026-07-31 | LAB Jun avg: -14.30% median: -17.87% win: 20% σ: 19.47% n: 5 2022-04-12 → 2026-07-31 | LAB Jul avg: 12.09% median: 10.83% win: 80% σ: 15.29% n: 5 2022-04-12 → 2026-07-31 | LAB Aug avg: 2.38% median: -3.84% win: 25% σ: 13.43% n: 4 2022-04-12 → 2026-07-31 (current) | LAB Sep avg: -7.88% median: -6.36% win: 25% σ: 10.71% n: 4 2022-04-12 → 2026-07-31 | LAB Oct avg: -7.56% median: -3.07% win: 50% σ: 17.03% n: 4 2022-04-12 → 2026-07-31 | LAB Nov avg: 16.58% median: 21.40% win: 75% σ: 15.90% n: 4 2022-04-12 → 2026-07-31 | LAB Dec avg: -12.43% median: -14.50% win: 0% σ: 5.07% n: 4 2022-04-12 → 2026-07-31 |